Short Interest in Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) Drops By 98.0%

Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) was the target of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 800 shares, a decrease of 98.0% from the October 15th total of 39,700 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Quantum Genomics Société Anonyme Stock Performance

OTCMKTS QNNTF remained flat at $0.10 during trading on Thursday. The stock has a fifty day moving average of $0.10 and a two-hundred day moving average of $0.10. Quantum Genomics Société Anonyme has a 1 year low of $0.10 and a 1 year high of $0.10.

About Quantum Genomics Société Anonyme

Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure.